|1.||Schmidt, Reinhold: 2 articles (02/2004 - 02/2004)|
|2.||Günther, Andreas: 2 articles (02/2004 - 02/2004)|
|3.||Friedrich, Ivar: 2 articles (02/2004 - 02/2004)|
|4.||Splittgerber, Fred H: 2 articles (02/2004 - 02/2004)|
|5.||Börgermann, Jochen: 2 articles (02/2004 - 02/2004)|
|6.||Seeger, Werner: 2 articles (02/2004 - 02/2004)|
|7.||Tsoutsos, D A: 1 article (09/2006)|
|8.||Papadopoulos, S: 1 article (09/2006)|
|9.||Karabinis, A: 1 article (09/2006)|
|10.||Tsangaris, H: 1 article (09/2006)|
|1.||Lung Diseases (Lung Disease)
02/01/2004 - "We investigated the efficacy of bronchoscopic administration of a bovine natural lung surfactant extract (Alveofact) to improve gas exchange and lung mechanics after heterologous left lung transplantation in foxhounds (+4 degrees C ischemia for 24 hours, conservation with Euro-Collins solution). "
02/01/2004 - "We performed heterologous, left lung transplantation (+4 degrees C ischemia; 24 hours, Euro-Collins solution) in 6 foxhounds (untreated) and in 6 animals that received calf lung surfactant extract (Alveofact) prior to explantation (only donor lung; 50 mg/kg body weight) and immediately after onset of reperfusion (both lungs, 200 mg/kg body weight). "
|3.||Newborn Respiratory Distress Syndrome
11/01/1996 - "[Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study]."
07/01/2003 - "The aim of the study was to compare the treatment regimen of three natural surfactants of different extraction and formulation (Alveofact [Surfactant A = SA], Poractant [Surfactant B = SB] and Beractant [Surfactant C = SC]) in neonatal respiratory distress syndrome (RDS). "
|4.||Birth Weight (Birth Weights)
|5.||Body Weight (Weight, Body)
11/01/1998 - "Early treatment: 100 mg/kg body weight bovine surfactant (SF-RI1, Alveofact; Dr K. "
07/01/1996 - "Three hundred milligrams of natural surfactant/kg body weight (Alveofact) was delivered bronchoscopically in separate doses to each segment of both lungs. "
04/01/1995 - "We therefore investigated the distribution of the first (100 mg/kg body weight) and second dose (50 mg/kg body weight) of surfactant (Alveofact) in lung-lavaged rabbits (n = 6). "
02/01/2004 - "Animals received either no surfactant therapy (untreated controls, n = 6) or 50 mg/kg body weight (prior to explantation, only graft) and 200 mg/kg body weight Alveofact (immediately after reperfusion, both lungs, n = 6). "
10/01/1997 - "Surfactant (Alveofact, 100 mg/kg body weight) was nebulised using the MiniNEB nebuliser, or instilled, in 12 rabbits with severe respiratory failure induced by lung lavage. "
|2.||Surface-Active Agents (Surfactants)
|5.||Exosurf (Exosurf Neonatal)
|6.||Interleukin-6 (Interleukin 6)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|8.||Staphylococcal Protein A (A, Protein)